Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146604504> ?p ?o ?g. }
- W2146604504 abstract "Objective. An increasing number of patients with prostate cancer develop hormone-refractory disease after standard treatment modalities. In these patients, early clinical trials with chemotherapy produced disappointing response rates. However, clinical trials that employ response criteria such as prostate-specific antigen (PSA) and clinical benefit response have produced encouraging responses. This article reviews current and future treatment options for the management of hormone-refractory prostate cancer. Data Sources. A MEDLINE search for the years 1978 to 1998 was completed. The following terms were used in our search: prostate cancer, hormone-refractory, treatment, and chemotherapy. Relevant articles referenced in the literature obtained in our MEDLINE search were reviewed. Study Selection. Randomized and nonrandomized clinical trials were used in our review. Clinical trials using prostate-specific antigen or a palliation of symptoms as primary criteria for response were given priority. Data Synthesis. Several genetic alterations, including the overexpression of bcl-2 or mutations in p53, may lead to the development of hormone-refractory prostate cancer. Agents such as estramustine and taxanes, which affect microtubule function and potentially modulate bcl-2, appear to be particularly active in the treatment of hormone-refractory prostate cancer. In addition, mitoxantrone as well as other agents has been shown to be beneficial in improving the quality of life in patients with hormone-refractory prostate cancer. Conclusion. Hormone-refractory prostate cancer is not a chemotherapy-resistant disease as once believed; significant progress in the treatment of hormone-refractory prostate cancer has been made with new combinations of chemotherapy agents. Promising new treatments are currently under evaluation to assess their potential benefit over the standard treatment modalities that are currently available." @default.
- W2146604504 created "2016-06-24" @default.
- W2146604504 creator A5007273172 @default.
- W2146604504 creator A5020553713 @default.
- W2146604504 creator A5090879940 @default.
- W2146604504 date "1999-03-01" @default.
- W2146604504 modified "2023-09-25" @default.
- W2146604504 title "Treatment of hormone-refractory prostate cancer" @default.
- W2146604504 cites W116367892 @default.
- W2146604504 cites W122252942 @default.
- W2146604504 cites W1252490173 @default.
- W2146604504 cites W127182478 @default.
- W2146604504 cites W165132104 @default.
- W2146604504 cites W1797512951 @default.
- W2146604504 cites W1893347245 @default.
- W2146604504 cites W1905989945 @default.
- W2146604504 cites W191328410 @default.
- W2146604504 cites W1949157693 @default.
- W2146604504 cites W1951802477 @default.
- W2146604504 cites W1964112264 @default.
- W2146604504 cites W1964390756 @default.
- W2146604504 cites W1967290941 @default.
- W2146604504 cites W1969577084 @default.
- W2146604504 cites W1972094304 @default.
- W2146604504 cites W1972422162 @default.
- W2146604504 cites W1972580962 @default.
- W2146604504 cites W1980850919 @default.
- W2146604504 cites W1981747790 @default.
- W2146604504 cites W1984749582 @default.
- W2146604504 cites W1989871631 @default.
- W2146604504 cites W1994622746 @default.
- W2146604504 cites W1995022549 @default.
- W2146604504 cites W2003024052 @default.
- W2146604504 cites W2005271337 @default.
- W2146604504 cites W2011045319 @default.
- W2146604504 cites W2013120447 @default.
- W2146604504 cites W2014145760 @default.
- W2146604504 cites W2015264448 @default.
- W2146604504 cites W2017782880 @default.
- W2146604504 cites W2024404898 @default.
- W2146604504 cites W2026203123 @default.
- W2146604504 cites W2029676564 @default.
- W2146604504 cites W2035159808 @default.
- W2146604504 cites W2037934639 @default.
- W2146604504 cites W2044458543 @default.
- W2146604504 cites W2045473276 @default.
- W2146604504 cites W2055825014 @default.
- W2146604504 cites W2057773030 @default.
- W2146604504 cites W2059746580 @default.
- W2146604504 cites W2061129859 @default.
- W2146604504 cites W2061686178 @default.
- W2146604504 cites W2063933228 @default.
- W2146604504 cites W2068776651 @default.
- W2146604504 cites W2069791479 @default.
- W2146604504 cites W2072673199 @default.
- W2146604504 cites W2074544671 @default.
- W2146604504 cites W2074613446 @default.
- W2146604504 cites W2076915947 @default.
- W2146604504 cites W2094648349 @default.
- W2146604504 cites W2116519001 @default.
- W2146604504 cites W2117399653 @default.
- W2146604504 cites W2120466617 @default.
- W2146604504 cites W2121146904 @default.
- W2146604504 cites W2125437092 @default.
- W2146604504 cites W2126134811 @default.
- W2146604504 cites W2129630152 @default.
- W2146604504 cites W2134313753 @default.
- W2146604504 cites W2134979684 @default.
- W2146604504 cites W2135352785 @default.
- W2146604504 cites W2136456463 @default.
- W2146604504 cites W2142365640 @default.
- W2146604504 cites W2155323589 @default.
- W2146604504 cites W2155510257 @default.
- W2146604504 cites W2164818959 @default.
- W2146604504 cites W2177330869 @default.
- W2146604504 cites W2204115562 @default.
- W2146604504 cites W2222589758 @default.
- W2146604504 cites W2238819470 @default.
- W2146604504 cites W2258872784 @default.
- W2146604504 cites W2270947610 @default.
- W2146604504 cites W2323888499 @default.
- W2146604504 cites W2340799873 @default.
- W2146604504 cites W2414325113 @default.
- W2146604504 cites W2415683488 @default.
- W2146604504 cites W2422116974 @default.
- W2146604504 cites W2434399598 @default.
- W2146604504 cites W2617245288 @default.
- W2146604504 cites W27466347 @default.
- W2146604504 cites W4249240580 @default.
- W2146604504 cites W4300619205 @default.
- W2146604504 cites W4322702022 @default.
- W2146604504 cites W57868472 @default.
- W2146604504 cites W61945152 @default.
- W2146604504 cites W96058809 @default.
- W2146604504 doi "https://doi.org/10.1177/107815529900500103" @default.
- W2146604504 hasPublicationYear "1999" @default.
- W2146604504 type Work @default.
- W2146604504 sameAs 2146604504 @default.
- W2146604504 citedByCount "0" @default.
- W2146604504 crossrefType "journal-article" @default.